Skip to content
AwardedPRTGoods

Maralixibat 9.5 Mg/mL Sol Oral Fr 30 mL

Published
Published 20 July 2026

Overview

Unidade Local de Saúde de Coimbra, EPE procured the pharmaceutical product Maralixibat 9.5 Mg/mL oral solution in 30 mL vials. The contract was awarded to Cencora 3PL Portugal, S.A. on 7 July 2026 for a value of €1,435,097.40.

Key details

Country
PRT
Status
Awarded
Category
Goods
Procedure
Selective
Published
20 July 2026
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
€1,435,097
Award date
7 July 2026
Winner
  • Cencora 3PL Portugal, S.A.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    20 July 2026

Contracting authority

  • Unidade Local de Saúde de Coimbra, EPE

    Procuring entity

    Coimbra, PRT

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Maralixibat 9.5 Mg/mL Sol Oral Fr 30 mL — won by Cencora 3PL Portugal, S.A. — Skim